The COVID-19 pandemic has posed unique risks to people with Alzheimer disease and dementia. The impact is widespread and significant from higher rates of psychiatric symptoms, at times present for many months following acute infection to neuropsychiatric disturbances as a result of lockdown measures, social isolation and grief. This symposium will discuss the impact of COVID 19 on the prevalence, risk factors, and types of psychiatric manifestations of individuals living with Alzheimer’s disease and related dementias along with potential treatments to ameliorate these symptoms and to adjust with loss. It will examine emerging neuropsychological research in this population, cover basic neuroscience and neurocognitive health, and provide providers, and caregivers with resources and cognitive exercises and coping skills to improve the physical and mental health of these individuals.
Registration information to follow shortly.
Dates and Times
Start: 11/5/2021 8:00 AM
End: 11/5/2021 11:00 PM
- Learn the prevalence rates and risk factors associated with psychiatric symptoms following COVID-19 in individuals with Alzheimer’s disease and related dementias.
- Learn about the different types of psychiatric symptoms following COVID-19 and its impact of functioning in individuals living with Alzheimer’s disease and related dementias.
- Learn about potential treatments that could improve psychiatric symptoms in individuals with Alzheimer’s disease and related dementias that contracted COVID-19.
- Summarize what is known about the most common neuropsychiatric symptoms in post-acute SARS-CoV-2.
- Discuss biological and environmental mechanisms that may account for these symptoms, particularly in older adults.
- Describe new longitudinal studies that will monitor neuropsychiatric symptoms and neurobiology in post-acute SARS-CoV-2.
- Learn about basic neuroscience including structure, function and chemistry of the brain, understanding brain disorders, clinical signs and symptoms of various neuropsychiatric and neurocognitive disorders and various diagnostic techniques.
- Learn about Neurocognitive health including nutrition and brain healthy foods such as MIND diet, physical exercise, mental and cognitive exercise such as yoga, meditation, mindfulness and how to implement neurocognitive health in order to improve physical, mental and cognitive health as well as improving the risk factors for Dementia.
- Learn about various intervention of neurocognitive health strategy including Preventive aspect of dementia which includes early diagnosis and treatment, early neurocognitive health interventions Including implementing a lifestyle change and holistic health strategies to improve mental, physical and cognitive health & quality of life ultimately slowing down the progression of dementia.
- Review and learn the stages of grieving as well as complicated grief.
- Learn how the pandemic has affected the natural process of grieving for patients with serious illness and their respective families.
- Discuss and learn the role of palliative care and interventions available that can help support and provide best care for patients with Alzheimer’s disease affected by the COVID-19 pandemic as well as their families.
The School of Medicine, State University of New York at Stony Brook, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The School of Medicine, State University of New York at Stony Brook designates this live activity for a maximum of 3.00 AMA PRA Category 1 Credit(s) ™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.